112 related articles for article (PubMed ID: 8704423)
1. [Preliminary study on early fibrosis of chronic hepatitis B treated with Ginkgo biloba Composita].
Li W; Dai QT; Liu ZE
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Oct; 15(10):593-5. PubMed ID: 8704423
[TBL] [Abstract][Full Text] [Related]
2. [Procollagen III and laminin in chronic viral hepatopathies].
Montalto G; Soresi M; Aragona F; Tripi S; Carroccio A; Anastasi G; Magliarisi C; Barresi E; Notarbartolo A
Presse Med; 1996 Jan; 25(2):59-62. PubMed ID: 8745719
[TBL] [Abstract][Full Text] [Related]
3. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial].
Yin SS; Wang BE; Wang TL; Jia JD; Qian LX
Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):467-70. PubMed ID: 15329205
[TBL] [Abstract][Full Text] [Related]
4. Decrease in serum levels of markers of hepatic connective tissue turnover during and after treatment of chronic hepatitis B with interferon-alpha.
Teran JC; Mullen KD; Hoofnagle JH; McCullough AJ
Hepatology; 1994 Apr; 19(4):849-56. PubMed ID: 8138256
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of serum laminin P1, procollagen-III peptides, and N-acetyl-beta-glucosaminidase for monitoring the activity of liver fibrosis.
Schneider M; Voss B; Högemann B; Eberhardt G; Gerlach U
Hepatogastroenterology; 1989 Dec; 36(6):506-10. PubMed ID: 2693303
[TBL] [Abstract][Full Text] [Related]
6. [Comparison on efficacy in treating liver fibrosis of chronic hepatitis B between Astragalus Polygonum anti-fibrosis decoction and jinshuibao capsule].
Chen H; Weng L
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 Apr; 20(4):255-7. PubMed ID: 11789260
[TBL] [Abstract][Full Text] [Related]
7. [Correlation of serum markers with fibrosis staging in chronic viral hepatitis].
Wang T; Wang B; Liu X
Zhonghua Bing Li Xue Za Zhi; 1998 Jun; 27(3):185-90. PubMed ID: 11244978
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of pre- and post-treatmental hepatohistology with heavy dosage of Paeonia rubra on chronic active hepatitis caused liver fibrosis].
Yang DG
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1994 Apr; 14(4):207-9, 195. PubMed ID: 7950194
[TBL] [Abstract][Full Text] [Related]
9. [Serial changes in serum levels of laminin and type III procollagen N-terminal peptide after transarterial embolization (TAE) in hepatocellular carcinoma].
Matsuda H
Nihon Shokakibyo Gakkai Zasshi; 1991 Feb; 88(2):153-61. PubMed ID: 1851519
[TBL] [Abstract][Full Text] [Related]
10. Basement membrane-related and type III procollagen-related antigens in serum of patients with chronic viral liver disease.
Misaki M; Shima T; Yano Y; Sumita Y; Kano U; Murata T; Watanabe S; Suzuki S
Clin Chem; 1990 Mar; 36(3):522-4. PubMed ID: 2311224
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of serum type-III procollagen aminopropeptide in hepatitis B virus-related liver diseases.
Chang TT; Lin HC; Lee SD; Tsai YT; Lee FY; Jeng FS; Wu JC; Yeh PS; Lo KJ
Scand J Gastroenterol; 1989 Jun; 24(5):533-8. PubMed ID: 2762752
[TBL] [Abstract][Full Text] [Related]
12. Procollagen-III peptide and chronic viral C hepatitis.
Jeffers LJ; Coelho-Little ME; Cheinquer H; Vargas C; Civantos F; Alvarez L; Reddy KR; Parker T; de Medina M; Li X
Am J Gastroenterol; 1995 Sep; 90(9):1437-40. PubMed ID: 7661165
[TBL] [Abstract][Full Text] [Related]
13. [Supplemental Fuzhenghuayu capsule therapy for improving liver fibrosis markers in patients with chronic hepatitis B following unsatisfactory outcome of nucleos(t)ide analogue monotherapy].
Tian YL; Zhu XY; Yin WW; Zang ZD; Wang L; Fu XL
Zhonghua Gan Zang Bing Za Zhi; 2013 Jul; 21(7):514-8. PubMed ID: 24074710
[TBL] [Abstract][Full Text] [Related]
14. [Determination of serum procollagen-III peptide in chronic liver diseases. Clinical usefulness].
Pagani A; Zigliani P; Pranzo A; Galante T
Minerva Med; 1992 Nov; 83(11):715-20. PubMed ID: 1461542
[TBL] [Abstract][Full Text] [Related]
15. [Serum fibrosis markers in diagnosing liver fibrosis].
Liu J; Wang JY; Lu Y
Zhonghua Nei Ke Za Zhi; 2006 Jun; 45(6):475-7. PubMed ID: 16831325
[TBL] [Abstract][Full Text] [Related]
16. [Clinical study on relationship between liver-blood stasis and liver fibrosis].
Tang ZM; Ru QJ; Zhang ZE
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1997 Feb; 17(2):81-3. PubMed ID: 9812662
[TBL] [Abstract][Full Text] [Related]
17. Determination of serum fibrosis indexes in patients with chronic hepatitis and its significance.
Zheng M; Cai W; Weng H; Liu R
Chin Med J (Engl); 2003 Mar; 116(3):346-9. PubMed ID: 12781034
[TBL] [Abstract][Full Text] [Related]
18. [Serum variations of 2 markers of fibrogenesis in chronic hepatitis C treated with alpha interferon].
Soresi M; Bascone F; Agate V; Carroccio A; Barresi E; Cartabellotta A; Aragona F; Montalto G
Recenti Prog Med; 1997 Feb; 88(2):73-6. PubMed ID: 9148370
[TBL] [Abstract][Full Text] [Related]
19. Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitis. Relationship to liver histology and conventional liver tests.
Trinchet JC; Hartmann DJ; Pateron D; Laarif M; Callard P; Ville G; Beaugrand M
J Hepatol; 1991 Mar; 12(2):139-44. PubMed ID: 1711064
[TBL] [Abstract][Full Text] [Related]
20. [Serum aminoterminal procollagen type-III peptide in the diagnosis of chronic hepatopathies].
Solís-Herruzo JA; Morillas JD; Vargas J; Colina F; Castellano G; Muñoz Yagüe T; Estenoz J
Med Clin (Barc); 1992 May; 99(1):1-5. PubMed ID: 1602891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
